We recognize Tn as a highly sensitive and specific biomarker of myocardial injury that can reflect the severity of right ventricular dysfunction caused by APE, predict the risk of adverse outcomes such as short-term and long-term mortality in patients with APE, and provide a basis for the treatment choices and follow-up plans for patients with APE. Here, TNC is linked to apparent mineralocorticoid excess.